Harker, James A <br/><br/>
Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.  [electronic resource] 

 -  Journal of virology  Apr 2010 
 - 4073-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-5514 
<br/><br/><label>Standard No.: </label>10.1128/JVI.02014-09  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Viral--blood<br/>CD8-Positive T-Lymphocytes--immunology<br/>Female<br/>Interleukin-18--genetics<br/>Killer Cells, Natural--immunology<br/>Leukocyte Reduction Procedures<br/>Lung--pathology<br/>Mice<br/>Mice, Inbred BALB C<br/>Respiratory Syncytial Virus Infections--immunology<br/>Respiratory Syncytial Virus Vaccines--adverse effects<br/>Respiratory Syncytial Viruses--genetics<br/>Vaccines, Synthetic--adverse effects<br/>Viremia<br/>Weight Loss